Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: A double blind placebo controlled trial

European Journal of Clinical Pharmacology

Volumn 50, Issue 6, 1996, Pages 457-461

  Akerlund B ^a   Jarstrand, C ^a   Lindeke, B ^b   Sonnerborg A ^a   Akerblad A C ^c   Rasool, O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Swed Acad of Pharmaceutical Sci   (Sweden)

^c PFIZER INC   (United States)

Author keywords

Free radical generation; HIV T infection; N acetylcysteine treatment; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; CD4 ANTIGEN; CYSTEINE; FREE RADICAL; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS INFECTION;

ACETYLCYSTEINE; ADULT; AGED; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CYSTEINE; DOUBLE-BLIND METHOD; FEMALE; FREE RADICAL SCAVENGERS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; NITROBLUE TETRAZOLIUM; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029743762     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050140     Document Type: Article

References (26)

1. Baruchel S, Wainberg MA (1992) The role of oxidative stress in disease progression in individuals infected by human immunodeficiency virus. J Leukoc Biol 52:111-114
2. Sönnerborg A, Jarstrand C (1986) Nitroblue tetrazolium (NBT) reduction by neutrophilic granulocytes in patients with HTLV III infection. Scand J Inf Dis 18:101-103
3. Bundres JC, Trial J Musher MD, Rossen RD (1993) Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage I HIV infection. J Infect Dis 168:75-83
4. Sönnerborg A, Carlin G, Åkerlund B, Jarstrand C (1988) Increase in production of malondialdehyde in patients with HIV infection. Scand J Inf Dis 20:287-290
5. Rubin BY, Smith LJ, Hellerman GR, Linn RM, Richardson NK, Anderson SL (1988) Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factor. Cancer Res 48:6006-6610
6. Bashir S, Harris G, Denman MA, Blake DR, Winyard PG (1993) Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 52:659-666
7. Dworkin BM, Rosenthal WS, Wormser GP, Weiss L, Rehm S (1986) Selenium deficiency in the acquiered immune deficiency syndrome. JPEN 10:405-407
8. Beach RS, Mantero-Atienza E, Shor-Posner G, Javier J Szapocznik J, Morgan R, Sauberlich H, Cornwell P, Eisdorfer C, Baum M (1992) Specific nutrient abnormalities in asymtomatic HIV-1 infection. AIDS 6:701-708
9. Cathart R (1984) Vitamin C in the treatment of aquired immune deficiency syndrome. Med Hypothesis 14:423-433
10. Buhl R, Holroyd KJ, Mastrangeli A, Cantin AM, Jaffe HA, Wells FB, Saltini C, Crystal RG (1989)ii: Systemic glutathione deficiency in symptom free HIV seropositive individuals. Lancet 1294-1298
11. Eck HP, Gmunder H, Hartman M, Petzoldt D, Daniel V, Droge W (1989) Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV infected patients. Biol Chem Hoppe Seyler 370:101-108
12. Freed BM, Rapoport R, Lempert N (1987) Inhibition of early events in the human T-lymphocyte response to mitogens and alloalloantigens by hydrogen peroxide. Arch Surg 122:99-104
13. Carson DA, Sands S, Wasson DNB (1986) Lymphocyte dysfunction after DNA damage by toxic oxygen species. J Exp Med 163:746-751
14. Heffner JE, Repine JE (1989) Pulmonary strategies of antioxidant defence. Am Rev Respir Dis 140:531-554
15. Moldeus P, Cotgreave IA, Berggren M (1986) Lung protection by thiol-containing antioxidant: N-acetyleysteine. Respiration 50 (Suppl 1): 31-42
16. Johansson M, Lenngren S (1988) Determination of cysteine, glutathione and N-acetylcysteine in plasma by ion-pair reversed phase liquid chromatography and post-column derivatization. J Chromatogr 432:65-74
17. Boyum A (1986) Separation of leukocytes from blood and bone marrovv. Scand J Clin Lab Invest 21 [Suppl 97]: 9-29
18. Jarstrand C (1977) The NBT(nitroblue tetrazolium activity) of neutrophilic granulocytes in patients with influenza A. Scand J Inf Dis 9:5-7
19. Böttiger B, Blombäck M, Berntorp E (1988) HIV serology and lymphocyte subsets in relation to therapy and clinical development in haemophiliacs. Eur J Haematol 41:459-466
20. von Sydow M, Sönnerborg A, Gaines H, Strannergàrd O (1991) Interpheron α and tumor necrosis factor α in serum of patients at various stages of HlV-1 infection. AIDS Res Human Retrovirus 7:375-380
21. Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein W (1989) Patterns of T-lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J AIDS 2:63-69
22. Klebanoff S, Vadas M, Harlan J, Sparks L Gamble J, Agosti L (1986) Stimulation of neutrophils by tumor necrosis factor. J Immunol 136: 4220-4225
23. Bajal MS, Kew RR Webster RO, Hyers TM (1992) Priming of human neutrophil functions by tumor necrosis factor. Inflammation 16:241-249
24. Dröge W, Eck HP, Gmunder H, Mikne S (1991) Requirement for prooxidant and antioxidant states in T-cell mediated immune responses. Relevance for the pathogenetic mechanisms of AIDS? Klin Wochenschr 69:118-122
25. Roederer M, Staal F, Anderson M (1993) Dysregulation of leukocyte glulathione in AIDS. Ann NY Acad Sci 677:113-125
26. Schreck R, Rieber P, Bauerle PA (1992) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NFkB transkription factor and HIV 1. EMBO J 17:221-237